XML 84 R66.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 4,534 $ 6,822
2018 Long-Term Incentive Equity Plan [Member] | Cost Of Revenue [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 120 63
2018 Long-Term Incentive Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 1,221 948
2018 Long-Term Incentive Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 2,325 4,455
2018 Long-Term Incentive Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 517 296
PAVmed 2014 Equity Plan [Member] | Cost Of Revenue [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 44 37
PAVmed 2014 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 144 463
PAVmed 2014 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 5 173
PAVmed 2014 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 158 $ 387